WuXi AppTec Co., Ltd.
SHH: 603259.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ge Li
- Employees
- 39,414
- Headquarters
- Shanghai, China
- IPO year
- 2018
- Market cap
- CN¥264.1B
- Website
- https://www.wuxiapptec.com
Loading 603259…
Loading profile data…Frequently asked questions about 603259
What does WuXi AppTec Co., Ltd. (603259.SS) do?
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi C...
Where does 603259.SS trade?
WuXi AppTec Co., Ltd. (603259.SS) trades on the Shanghai Stock Exchange.
What sector is 603259.SS in?
WuXi AppTec Co., Ltd. (603259.SS) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of WuXi AppTec Co., Ltd.?
Ge Li is the chief executive officer of WuXi AppTec Co., Ltd. (603259.SS).
Where is WuXi AppTec Co., Ltd. headquartered?
WuXi AppTec Co., Ltd. is headquartered in China.
Does 603259.SS pay a dividend?
Yes — WuXi AppTec Co., Ltd. (603259.SS) paid a trailing twelve-month dividend of CNY 1.68 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603259.SS go public?
WuXi AppTec Co., Ltd. (603259.SS) completed its initial public offering in 2018.